Fugeia NV, established in 2008, focuses on developing innovative ingredients and nutrition technologies in the Food and Beverage and Nutrition industries. The company's slogan, "Boosting Wellness with Innovative Nutrition Technologies for Healthier Living," encapsulates its mission to promote health through its products. Notably, Fugeia NV has received a significant €3.50M Venture Round investment on 28 May 2008 from Tate & Lyle Ventures and Agri Investment Fund. The company's flagship product, an arabinoxylan-oligosaccharides (AXOS) ingredient derived from wholegrain wheat, offers numerous health benefits. It aids in preventing lifestyle diseases like diabetes, obesity, cardiovascular diseases, and cancer. In addition, Fugeia NV offers Prebiotic bread technology, aimed at increasing AXOS levels in bread, and AXOS-enriched beer technology to enhance the nutritional value of beer. These innovations cater to various market segments, including dairy and non-dairy beverages, ready-to-eat cereals, cookies and biscuits, bread and pastry, as well as dietary supplements and therapeutics. Fugeia NV's dedication to developing products that promote healthier living positions it as an attractive investment opportunity for venture capitalists seeking to support disruptive solutions in the nutrition and wellness sector.
No recent news or press coverage available for Fugeia NV.